← All trials
NCT04654676
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 15, 2018
- Primary completion
- Aug 31, 2019
- Completion date
- Aug 31, 2019
- First posted
- Dec 4, 2020
- Last posted
- Dec 19, 2020
- Enrollment
- 12
- Arms / groups
- — / —
- Source
- AACT · ingestion pipeline
Sponsors
- University Malaysia SarawakLead sponsor
- Sarawak General HospitalOverall official - principal investigator
- Sarawak General HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.